Cite
HARVARD Citation
Hosui, A. et al. (2021). Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA. Hepatology communications. 5 (12), pp. 2001-2008. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hosui, A. et al. (2021). Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA. Hepatology communications. 5 (12), pp. 2001-2008. [Online].